Half-year report · Q2

Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥5.2bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥2.8bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income−¥203m2024-07-01 → 2024-12-31Cons.Operating income
Operating income−¥455m2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income−¥198m2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥566m2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥449m2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax−¥212m2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥449m2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥222m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥662m2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥488m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income−¥222m2024-07-01 → 2024-12-31Cons.Profit loss
Net income−¥489m2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥6.6bnat 2024-12-31Cons.Assets
Total assets¥6.9bnat 2024-06-30Cons.Assets
Total assets¥7.1bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥557mat 2024-12-31Cons.Liabilities
Total liabilities¥697mat 2024-06-30Cons.Liabilities
Net assets / equity¥6.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.2bnat 2024-06-30Cons.Net assets
Net assets / equity¥6.4bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥4.8bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥4.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥98m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥881m2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥967m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥324m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥14m2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥172,0002024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥261m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥260m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-8.52024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.652023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio91.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.7%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥14m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2024-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥15m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥159m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥19m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31¥25m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥4m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31−¥132m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2024-07-01 → 2024-12-31¥183m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥173m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥11m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥3m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥39m
—segment totalrevenue2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥15m
—segment totalsegment profit2024-07-01 → 2024-12-31−¥45m
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥10m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥11m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥156m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥72m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥270m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-12-31¥165m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥157m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥8m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-12-31−¥701,000
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥43m
—segment totalrevenue2023-07-01 → 2023-12-31¥2.9bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥2.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥11m
—segment totalsegment profit2023-07-01 → 2023-12-31−¥299m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember4426800
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1692
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember435542
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0167
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember352000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0135
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember330800
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0126
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember323000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0123
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember318900
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0122
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember250000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0096
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember220100
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0084
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember215800
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0082
Number of shares heldCurrentQuarterInstant11498542
Shareholding ratioCurrentQuarterInstant0.4396
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember26149100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember261491
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember9100
Number of shares issued shares voting rightsCurrentQuarterInstant26158200
Number of voting rights issued shares voting rightsCurrentQuarterInstant261491
Cash and depositsPrior1YearInstant4790024000JPY
Cash and depositsCurrentQuarterInstant4563180000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant428934000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant479771000JPY
Short term investment securitiesPrior1YearInstant-JPY
Short term investment securitiesCurrentQuarterInstant300000000JPY
MerchandisePrior1YearInstant443711000JPY
MerchandiseCurrentQuarterInstant329090000JPY
Work in processPrior1YearInstant244500000JPY
Work in processCurrentQuarterInstant207516000JPY
Raw materials and suppliesPrior1YearInstant432658000JPY
Raw materials and suppliesCurrentQuarterInstant401417000JPY
Other caPrior1YearInstant425460000JPY
Other caCurrentQuarterInstant114934000JPY
Allowance for doubtful accounts caPrior1YearInstant-144000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-144000JPY
Current assetsPrior1YearInstant6765144000JPY
Current assetsCurrentQuarterInstant6395766000JPY
Property plant and equipmentPrior1YearInstant20316000JPY
Property plant and equipmentCurrentQuarterInstant39709000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass